Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(18/week)
Philippines
(7/week)
India
(6/week)
United States of America
(2/week)
Taiwan
(2/week)
View all
(43/week)
News
United States
(1374/week)
Manufacturing
(661/week)
Technology
(1462/week)
Energy
(543/week)
Environment
(523/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
AcelRx Pharmaceuticals, Inc.
Jan 19, 2021
AcelRx Announces Underwritten Public Offering of Common Stock
Jan 19, 2021
AcelRx Announces an Investigator-Initiated Study of DSUVIA® in Cardiac Surgery Enhanced Recovery Regimen
Jan 14, 2021
AcelRx Announces Year-End 2020 Metrics and Review of 2020 Achievements
Dec 10, 2020
AcelRx Pharmaceuticals Announces Publication of Clinical Data on Decreased Postoperative Opioid Requirements and Enhanced Postanesthesia Recovery Following Perioperative Use of DSUVIA®
Dec 10, 2020
AcelRx Announces $10 Million Registered Direct Common Stock Offering
Dec 09, 2020
AcelRx Pharmaceuticals to Present at LD Micro Main Event
Dec 04, 2020
AcelRx Pharmaceuticals Announces Partnership with the National Rural Health Association
Nov 18, 2020
AcelRx Pharmaceuticals Announces Commentary in Practical Pain Management on Previously Published Clinical Data on Preoperative Administration of DSUVIA®
Nov 05, 2020
AcelRx Pharmaceuticals Reports Third Quarter 2020 Financial Results
Sep 29, 2020
AcelRx to Host Virtual KOL Event on Perioperative Use of DSUVIA®
Sep 22, 2020
AcelRx Awarded U.S. Army Contract for DSUVIA®
Sep 14, 2020
AcelRx Announces DSUVIA® Added to the U.S. Department of Defense's Joint Deployment Formulary
Sep 10, 2020
AcelRx Pharmaceuticals to Present at Two Upcoming Conferences
Aug 24, 2020
AcelRx Announces an Investigator-Initiated Study of DSUVIA® in Orthopedic Patients in the Perioperative Setting
Aug 19, 2020
AcelRx Pharmaceuticals Announces Publication of Clinical Data on Reduced Opioid Use and Reduced Time in the Postanesthesia Care Unit (PACU) Following Preoperative Administration of DSUVIA®
Aug 10, 2020
AcelRx Pharmaceuticals Reports Second Quarter 2020 Financial Results
Aug 03, 2020
AcelRx to Host Second Quarter 2020 Financial Results Call and Webcast on Monday, August 10th, 2020
Jul 23, 2020
AcelRx Announces Exclusive Distribution and Promotion Partnership for DSUVIA®
Jul 23, 2020
AcelRx Announces $10 Million Common Stock Offering Priced At The Market
Jun 01, 2020
AcelRx Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
Page 1
››
Latest News
Sep 13, 2024
Asia-Pacific Multiple-Element Gas Container Industry Research 2023-2033: Hydrogen Fuel Cells,...
Sep 13, 2024
Simple Mobile Selected by California Public Utilities Commission as Wireless Partner for Re-Launch of...
Sep 13, 2024
France Crawler Excavator Market Assessment & Forecast 2024-2029, with Profiles of Prominent Vendors...
Sep 13, 2024
Directional Drilling Services Industry Report 2024: Market to Reach $29.3 Billion by 2030 - Expansion of...
Sep 13, 2024
$21.79 Bn Vegan Cosmetics and Personal Care Ingredients Markets with L'Oreal, Lush Retail, Pacifica...
Sep 13, 2024
Serving Those Who Serve: F45 Training Honors Veterans by Creating Special Franchise Opportunities Within the...
Sep 13, 2024
MGE Energy Issues September 2024 'Inside View'
Sep 13, 2024
Saudi Arabia Construction Equipment Market Strategic Assessment & Forecast 2024-2029: Focus on Green...
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
View All Events